Search Results | Scholarly Articles, Journals, and E-Books

Select item for more details and to access through your institution.

Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 547, doi. 10.1038/sj.leu.2404072
By:
- Desta, F.;
- Christiansen, D. H.;
- Andersen, M. K.;
- Pedersen-Bjergaard, J.
Publication type:
Article
Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 444, doi. 10.1038/sj.leu.2404055
By:
- Sanderson, R. N.;
- Johnson, P. R. E.;
- Moorman, A. V.;
- Roman, E.;
- Willett, E.;
- Taylor, P. R.;
- Proctor, S. J.;
- Bown, N.;
- Ogston, S.;
- Bowen, D. T.
Publication type:
Article
High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 498, doi. 10.1038/sj.leu.2404073
By:
- Sainz-Perez, A.;
- Gary-Gouy, H.;
- Portier, A.;
- Davi, F.;
- Merle-Beral, H.;
- Galanaud, P.;
- Dalloul, A.
Publication type:
Article
Target for cancer therapy: proliferating cells or stem cells.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 385, doi. 10.1038/sj.leu.2404075
By:
- Blagosklonny, M. V.
Publication type:
Article
Increase of CCR7− CD45RA+ CD8 T cells (TEMRA) in chronic graft-versus-host disease.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 545, doi. 10.1038/sj.leu.2404079
By:
- D'Asaro, M.;
- Dieli, F.;
- Caccamo, N.;
- Musso, M.;
- Porretto, F.;
- Salerno, A.
Publication type:
Article
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 463, doi. 10.1038/sj.leu.2404080
By:
- Kiladjian, J.-J.;
- Bourgeois, E.;
- Lobe, I.;
- Braun, T.;
- Visentin, G.;
- Bourhis, J.-H.;
- Fenaux, P.;
- Chouaib, S.;
- Caignard, A.
Publication type:
Article
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 471, doi. 10.1038/sj.leu.2404081
By:
- Quentmeier, H.;
- MacLeod, R. A. F.;
- Zaborski, M.;
- Drexler, H. G.
Publication type:
Article
Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations.
Published in:
2006
By:
- Burmeister, T.;
- Marschalek, R.;
- Schneider, B.;
- Meyer, C.;
- Gökbuget, N.;
- Schwartz, S.;
- Hoelzer, D.;
- Thiel, E.;
- Gökbuget, N
Publication type:
journal article
Reply to Pittner et al.
Published in:
2006
By:
- Zucchetto, A.;
- Bomben, R.;
- Dal Bo, M.;
- Bulian, P.;
- Benedetti, D.;
- Nanni, P.;
- del Poeta, G.;
- Degan, M.;
- Gattei, V.
Publication type:
Letter
Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 404, doi. 10.1038/sj.leu.2404090
By:
- Heil, G.;
- Hoelzer, D.;
- Sanz, M. A.;
- Lechner, K.;
- Noens, L.;
- Szer, J.;
- Ganser, A.;
- Matcham, J.;
- Renwick, J.
Publication type:
Article
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 410, doi. 10.1038/sj.leu.2404083
By:
- Stams, W. A. G.;
- Beverloo, H. B.;
- den Boer, M. L.;
- de Menezes, R. X.;
- Stigter, R. L.;
- van Drunen, E.;
- Ramakers-van-Woerden, N. L.;
- Loonen, A. H.;
- van Wering, E. R.;
- Janka-Schaub, G. E.;
- Pieters, R.
Publication type:
Article
JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 534, doi. 10.1038/sj.leu.2404086
By:
- Vizmanos, J. L.;
- Ormazábal, C.;
- Larráyoz, M. J.;
- Cross, N. C. P.;
- Calasanz, M. J.
Publication type:
Article
CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.
Published in:
2006
By:
- Zucchetto, A.;
- Bomben, R.;
- Dal Bo, M.;
- Bulian, P.;
- Benedetti, D.;
- Nanni, P.;
- del Poeta, G.;
- Degan, M.;
- Gattei, V.
Publication type:
Letter
Reply to ‘CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance’ by Zucchetto et al.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 528, doi. 10.1038/sj.leu.2404088
By:
- Pittner, B. T.;
- Shanafelt, T. D.;
- Kay, N. E.;
- Jelinek, D. F.
Publication type:
Article
Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 392, doi. 10.1038/sj.leu.2404084
By:
- Granot, T.;
- Milhas, D.;
- Carpentier, S.;
- Dagan, A.;
- Ségui, B.;
- Gatt, S.;
- Levade, T.
Publication type:
Article
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 542, doi. 10.1038/sj.leu.2404085
By:
- Pérez-Simón, J. A.;
- Sureda, A.;
- Fernández-Aviles, F.;
- Sampol, A.;
- Cabrera, J. R.;
- Caballero, D.;
- Martino, R.;
- Petit, J.;
- Tomás, J. F.;
- Moraleda, J. M.;
- Alegre, A.;
- Cañizo, C.;
- Brunet, S.;
- Rosiñol, L.;
- Lahuerta, J.;
- Díez-Martín, J. L.;
- León, A.;
- García, A.;
- Vazquez, L.;
- Sierra, J.
Publication type:
Article
ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 526, doi. 10.1038/sj.leu.2404091
By:
- Gumy-Pause, F.;
- Wacker, P.;
- Maillet, P.;
- Betts, D. R.;
- Sappino, A.-P.
Publication type:
Article
Reply to ‘ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia’ by Gumy-Pause et al.
Published in:
2006
By:
- Meier, M.;
- den Boer, M. L.;
- Hall, A. G.;
- Irving, J. A. E.;
- Passier, M.;
- Minto, L.;
- van Wering, E. R.;
- Janka-Schaub, G. E.;
- Pieters, R.
Publication type:
Letter
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 437, doi. 10.1038/sj.leu.2404093
By:
- Ritter, M.;
- Kattmann, D.;
- Teichler, S.;
- Hartmann, O.;
- Samuelsson, M. K. R.;
- Burchert, A.;
- Bach, J.-P.;
- Kim, T. D.;
- Berwanger, B.;
- Thiede, C.;
- Jäger, R.;
- Ehninger, G.;
- Schäfer, H.;
- Ueki, N.;
- Hayman, M. J.;
- Eilers, M.;
- Neubauer, A.
Publication type:
Article
Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 539, doi. 10.1038/sj.leu.2404094
By:
- Sivertsen, E. A.;
- Galteland, E.;
- Mu, D.;
- Holte, H.;
- Meza-Zepeda, L.;
- Myklebost, O.;
- Patzke, S.;
- Smeland, E. B.;
- Stokke, T.
Publication type:
Article
Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 530, doi. 10.1038/sj.leu.2404095
By:
- McCann, K. J.;
- Johnson, P. W. M.;
- Stevenson, F. K.;
- Ottensmeier, C. H.
Publication type:
Article
Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 433, doi. 10.1038/sj.leu.2404097
By:
- Roumier, C.;
- Lejeune-Dumoulin, S.;
- Renneville, A.;
- Goethgeluck, A. S.;
- Philippe, N.;
- Fenaux, P.;
- Preudhomme, C.
Publication type:
Article
Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
Published in:
2006
By:
- Quiney, C.;
- Billard, C.;
- Faussat, A. M.;
- Salanoubat, C.;
- Ensaf, A.;
- Naït-Si, Y.;
- Fourneron, J. D.;
- Kolb, J.-P.;
- Naït-Si, Y
Publication type:
journal article
Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 477, doi. 10.1038/sj.leu.2404100
By:
- Maywald, O.;
- Pfirrmann, M.;
- Berger, U.;
- Breitscheidel, L.;
- Gratwohl, A.;
- Kolb, H.-J.;
- Beelen, D. W.;
- Tobler, A.;
- Metzgeroth, G.;
- Gnad, S. U.;
- Hochhaus, A.;
- Hasford, J.;
- Hehlmann, R.;
- Reiter, A.
Publication type:
Article
High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia.
Published in:
2006
By:
- Mansour, M. R.;
- Linch, D. C.;
- Foroni, L.;
- Goldstone, A. H.;
- Gale, R. E.
Publication type:
Letter
Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.
Published in:
2006
By:
- DiMartino, J. F.;
- Lacayo, N. J.;
- Varadi, M.;
- Li, L.;
- Saraiya, C.;
- Ravindranath, Y.;
- Yu, R.;
- Sikic, B. I.;
- Raimondi, S. C.;
- Dahl, G. V.
Publication type:
journal article
A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 536, doi. 10.1038/sj.leu.2404104
By:
- Adélaïde, J.;
- Pérot, C.;
- Gelsi-Boyer, V.;
- Pautas, C.;
- Murati, A.;
- Copie-Bergman, C.;
- Imbert, M.;
- Chaffanet, M.;
- Birnbaum, D.;
- Mozziconacci, M.-J.
Publication type:
Article
The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 417, doi. 10.1038/sj.leu.2404105
By:
- Yang, L. V.;
- Wan, J.;
- Ge, Y.;
- Fu, Z.;
- Kim, S. Y.;
- Fujiwara, Y.;
- Taub, J. W.;
- Matherly, L. H.;
- Eliason, J.;
- Li, L.
Publication type:
Article
Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onset.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 485, doi. 10.1038/sj.leu.2404106
By:
- Matsuda, K.;
- Matsuzaki, S.;
- Miki, J.;
- Hidaka, E.;
- Yanagisawa, R.;
- Nakazawa, Y.;
- Sakashita, K.;
- Kamijo, T.;
- Asami, K.;
- Sano, K.;
- Koike, K.
Publication type:
Article
Reply to Herens et al.
Published in:
2006
By:
- Lo Vasco, V. R.;
- Follo, M. Y.;
- Cocco, L.
Publication type:
Letter
Inositide-specific phospholipase c β1 gene deletion is a rare event in myelodysplastic syndromes.
Published in:
2006
By:
- Herens, C.;
- Ketelslegers, O.;
- Tassin, F.;
- Hansen, S.;
- Bours, V.
Publication type:
Letter
Reply to Lo Vasco et al.
Published in:
2006
By:
- Herens, C.;
- Ketelslegers, O.;
- Tassin, F.;
- Hansen, S.;
- Bours, V.
Publication type:
Letter
TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 505, doi. 10.1038/sj.leu.2404112
By:
- Sandberg, Y.;
- Almeida, J.;
- Gonzalez, M.;
- Lima, M.;
- Bárcena, P.;
- Szczepañski, T.;
- van Gastel-Mol, E. J.;
- Wind, H.;
- Balanzategui, A.;
- van Dongen, J. J. M.;
- Miguel, J. F. San;
- Orfao, A.;
- Langerak, A. W.
Publication type:
Article
Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 514, doi. 10.1038/sj.leu.2404113
By:
- Ringshausen, I.;
- Oelsner, M.;
- Weick, K.;
- Bogner, C.;
- Peschel, C.;
- Decker, T.
Publication type:
Article
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 400, doi. 10.1038/sj.leu.2404115
By:
- D. Rea;
- Legros, L.;
- Raffoux, E.;
- Thomas, X.;
- Turlure, P.;
- Maury, S.;
- Dupriez, B.;
- Pigneux, A.;
- Choufi, B.;
- Reman, O.;
- Stéphane, D.;
- Royer, B.;
- Vigier, M.;
- Ojeda-Uribe, M.;
- Recher, C.;
- Dombret, H.;
- Huguet, F.;
- Rousselot, P.
Publication type:
Article
Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Published in:
Leukemia (08876924), 2006, v. 20, n. 3, p. 458, doi. 10.1038/sj.leu.2404119
By:
- Matsui, W. H.;
- Brodsky, R. A.;
- Smith, B. D.;
- Borowitz, M. J.;
- Jones, R. J.
Publication type:
Article

Found: 36

Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.

Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia.

High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.

Target for cancer therapy: proliferating cells or stem cells.

Increase of CCR7<sup>−</sup> CD45RA<sup>+</sup> CD8 T cells (T<sub>EMRA</sub>) in chronic graft-versus-host disease.

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations.

Reply to Pittner et al.

Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia.

Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.

JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients.

CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.

Reply to ‘CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance’ by Zucchetto et al.

Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs.

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.

ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

Reply to ‘ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia’ by Gumy-Pause et al.

Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia.

Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas.

Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?

Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.

Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.

Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.

High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia.

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.

A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.

The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells.

Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onset.

Reply to Herens et al.

Inositide-specific phospholipase c β1 gene deletion is a rare event in myelodysplastic syndromes.

Reply to Lo Vasco et al.

TCRγδ<sup>+</sup> large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ<sup>+</sup> T-cells.

Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.

Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.